CTSK and hereditary clear cell renal cell carcinoma: In 2019, Chen et al. described seven cases designated as “sporadic renal cell carcinomas with eosinophilic and vacuolated cells”, characterized by cathepsin K immunoexpression and inactivating mutations of the TSC2 and mTOR activating mutations [60].